379 related articles for article (PubMed ID: 23012332)
1. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I
Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S
Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658
[TBL] [Abstract][Full Text] [Related]
4. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
5. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.
Karch A; Llorens F; Schmitz M; Arora AS; Zafar S; Lange P; Schmidt C; Zerr I
J Alzheimers Dis; 2016 Oct; 54(4):1385-1393. PubMed ID: 27589519
[TBL] [Abstract][Full Text] [Related]
6. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
[TBL] [Abstract][Full Text] [Related]
8. Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease.
Cseh EK; Veres G; Danics K; Szalárdy L; Nánási N; Klivényi P; Vécsei L; Zádori D
Ideggyogy Sz; 2019 Jan; 72(1-2):39-47. PubMed ID: 30785245
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
Skillbäck T; Rosén C; Asztely F; Mattsson N; Blennow K; Zetterberg H
JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases.
Rohan Z; Smetakova M; Kukal J; Rusina R; Matej R
BMC Neurol; 2015 Mar; 15():50. PubMed ID: 25886404
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.
Llorens F; Karch A; Golanska E; Schmitz M; Lange P; Sikorska B; Liberski PP; Zerr I
Dement Geriatr Cogn Disord; 2017; 43(1-2):71-80. PubMed ID: 28056460
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach.
Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY
Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
Humpel C; Benke T
Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
[TBL] [Abstract][Full Text] [Related]
16. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
17. High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease.
Abu-Rumeileh S; Halbgebauer S; Bentivenga GM; Barba L; Baiardi S; Mastrangelo A; Oeckl P; Steinacker P; Mammana A; Capellari S; Otto M; Parchi P
Ann Clin Transl Neurol; 2023 Oct; 10(10):1904-1909. PubMed ID: 37553789
[TBL] [Abstract][Full Text] [Related]
18. No added diagnostic value of non-phosphorylated tau fraction (p-tau
Goossens J; Bjerke M; Struyfs H; Niemantsverdriet E; Somers C; Van den Bossche T; Van Mossevelde S; De Vil B; Sieben A; Martin JJ; Cras P; Goeman J; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2017 Jul; 9(1):49. PubMed ID: 28709448
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia.
Llorens F; Schmitz M; Karch A; Cramm M; Lange P; Gherib K; Varges D; Schmidt C; Zerr I; Stoeck K
Alzheimers Dement; 2016 May; 12(5):577-89. PubMed ID: 26718584
[TBL] [Abstract][Full Text] [Related]
20. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
